The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells

BACKGROUND: Neuroendocrine (NE) differentiation represents a common feature of prostate cancer and is associated with accelerated disease progression and poor clinical outcome. Nowadays, there is no treatment for this aggressive form of prostate cancer. The aim of this study was to determine the inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Morell, C, Bort, A, Vara, D, Ramos-Torres, A, Rodríguez-Henche, N, Díaz-Laviada, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411672/
https://www.ncbi.nlm.nih.gov/pubmed/27324222
http://dx.doi.org/10.1038/pcan.2016.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411672/
https://www.ncbi.nlm.nih.gov/pubmed/27324222
http://dx.doi.org/10.1038/pcan.2016.19

Ejemplares similares